Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Bader-Meunier

Showing results (161-170 of 231) with videos related to

Pageof 24
Sort By:
Frontiers in Immunology|October 2, 2023
Curation and expansion of the Human Phenotype Ontology for systemic autoinflammatory diseases improves phenotype-driven disease-matchingWillem Maassen, Geertje Legger, Ovgu Kul Cinar, et al.
The Lancet Regional Health. Europe|May 4, 2022
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance studyNaïm Ouldali, Haleh Bagheri, Francesco Salvo, et al.
Annals of the Rheumatic Diseases|September 8, 2017
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiativeNoortje Groot, Nienke de Graeff, Stephen D Marks, et al.
Blood|June 28, 2014
Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patientsBénédicte Neven, Julie Bruneau, Marie-Claude Stolzenberg, et al.
Arthritis Research & Therapy|May 25, 2019
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trialIvan Foeldvari, Tamàs Constantin, Jelena Vojinović, et al.
Science Advances|July 17, 2019
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatmentNikaïa Smith, Mathieu P Rodero, Nassima Bekaddour, et al.
Annals of the Rheumatic Diseases|August 13, 2016
Consensus-based recommendations for the management of juvenile dermatomyositisFelicitas Bellutti Enders, Brigitte Bader-Meunier, Eileen Baildam, et al.
Rheumatology (Oxford, England)|April 25, 2025
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohortJade Cognard, Christine Pietrement, Audrey Laurent, et al.
Annals of the Rheumatic Diseases|May 6, 2017
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiativeNoortje Groot, Nienke de Graeff, Tadej Avcin, et al.
Rheumatology (Oxford, England)|February 10, 2025
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providersMatthew A Sherman, Rebecca Nicolai, Emily K Datyner, et al.
Pageof 24

Showing results (161-170 of 231) with videos related to

Sort By:
Pageof 24
Frontiers in Immunology|October 2, 2023
Curation and expansion of the Human Phenotype Ontology for systemic autoinflammatory diseases improves phenotype-driven disease-matchingWillem Maassen, Geertje Legger, Ovgu Kul Cinar, et al.
The Lancet Regional Health. Europe|May 4, 2022
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance studyNaïm Ouldali, Haleh Bagheri, Francesco Salvo, et al.
Annals of the Rheumatic Diseases|September 8, 2017
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiativeNoortje Groot, Nienke de Graeff, Stephen D Marks, et al.
Blood|June 28, 2014
Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patientsBénédicte Neven, Julie Bruneau, Marie-Claude Stolzenberg, et al.
Arthritis Research & Therapy|May 25, 2019
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trialIvan Foeldvari, Tamàs Constantin, Jelena Vojinović, et al.
Science Advances|July 17, 2019
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatmentNikaïa Smith, Mathieu P Rodero, Nassima Bekaddour, et al.
Annals of the Rheumatic Diseases|August 13, 2016
Consensus-based recommendations for the management of juvenile dermatomyositisFelicitas Bellutti Enders, Brigitte Bader-Meunier, Eileen Baildam, et al.
Rheumatology (Oxford, England)|April 25, 2025
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohortJade Cognard, Christine Pietrement, Audrey Laurent, et al.
Annals of the Rheumatic Diseases|May 6, 2017
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiativeNoortje Groot, Nienke de Graeff, Tadej Avcin, et al.
Rheumatology (Oxford, England)|February 10, 2025
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providersMatthew A Sherman, Rebecca Nicolai, Emily K Datyner, et al.
Pageof 24